{
  "url": "https://www.law.cornell.edu/regulations/new-york/10-NYCRR-12.21",
  "title": "N.Y. Comp. Codes R. & Regs. Tit. 10 ยง 12.21 - Determination of blood group and Rh type and administration of Rh immune globulin",
  "content": "N.Y. Comp. Codes R. & Regs. Tit. 10 ยง 12.21 - Determination of blood group and Rh type and administration of Rh immune globulin\n\nState Regulations\n(a) It shall be the duty of the physician, licensed midwife or nurse practitioner attending a pregnant person to take or cause to be taken a sample of their blood to determine blood group and Rh type in accordance with evidence based clinical guidelines. (b) It shall further be the duty of the attending physician, licensed midwife or nurse practitioner to evaluate every such patient for the risk of sensitization to Rho (D) antigen in accordance with evidence based clinical guidelines and if the use of Rh immune globulin is indicated, and the patient consents, to cause an appropriate dosage thereof to be administered as clinically indicated. Notes\nN.Y. Comp. Codes R. & Regs. Tit. 10\nยง\n12.21\n\nAmended\n\nNew\n\nYork State Register October 2, 2024/Volume XLVI, Issue 40, eff. 10/2/2024\n\nState regulations are updated quarterly; we currently have two versions available. Below is a\ncomparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare. No prior version found.",
  "url_type": "regulation",
  "source_index": 29368
}